Physician profile
Shelby Baker
NPI 1356411979
$1,441.36
in general payments reported to CMS, 2019-2025
17 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2021: $52.62 · 2022: $238 · 2023: $354 · 2024: $444 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $265.35 | 2024-2025 | Clareon |
| Dompe US, INC. | $221.36 | 2023-2024 | Oxervate |
| Horizon Therapeutics Plc | $124.99 | 2023 | Tepezza |
| Glaukos Corporation | $121.24 | 2022 | |
| Coopervision INC. | $99.96 | 2022 | |
| Maculogix, INC. | $97.23 | 2019 | |
| Apellis Pharmaceuticals, INC. | $95.82 | 2024-2025 | Syfovre |
| Amgen INC. | $89.74 | 2024 | Tepezza |
| Sun Pharmaceutical Industries INC. | $84.38 | 2023 | Cequa |
| Johnson & Johnson Vision Care, INC. | $69.81 | 2019-2022 | |
| Abbvie INC. | $44.66 | 2023-2024 | Durysta |
| Mallinckrodt Hospital Products INC. | $29.79 | 2021 | |
| Visioneering Technologies, INC. | $25.00 | 2019 | |
| Rxsight INC | $24.23 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Ani Pharmaceuticals, INC. | $18.92 | 2025 | Purified Cortrophin Gel |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $16.13 | 2019 | |
| Bausch & Lomb Americas INC. | $12.75 | 2023 | Vyzulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelby Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.